Dade International and Behring Diagnostics set to merge
This article was originally published in Clinica
Dade International and Behring Diagnostics, two of the top ten diagnostics companies, are to combine in an equity swap to create the world's largest independent clinical chemistry company. Dade will be the senior partner in the new business to be called Dade Behring.
You may also be interested in...
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says comparison to Sutent is standard control and allows better comparison to other combo regimens.
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been 52 so far in 2020, including Metacrine, Dyne, Athira and COMPASS.
In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.